Liberase Enzyme (Roche)
GARM COVID19
Phase 1 small_molecule active
Quick answer
Liberase Enzyme (Roche) for Pulmonary Alveolar Proteinosis is a Phase 1 program (small_molecule) at Black Diamond Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Black Diamond Therapeutics
- Indication
- Pulmonary Alveolar Proteinosis
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active